Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Base station apparatus and method for use in mobile communication system
Circuit board and display panel assembly having the same
Testing apparatus and testing method for telephone apparatus
Bullet lens design for the dasal seeker
Level-shift circuit, electro-optical device, and level shift method
Editing device and editing method
  Randomly Featured Patents
Device for forming a bunch of keys
Jack for subterranean meter pipes
Electronic device network supporting compression and decompression in electronic devices
Electric lock for a motor vehicle door
Digital automatic gain control for transceiver devices
Multi-disk player system
Passband resonator filter with predistorted quality factor Q
Parity checking arrangement for a remote switching unit network
Electric rotating machine capable of reducing performance deterioration due to discharge
Method and apparatus for a site-sensitive interactive chat network